Putative oncogenic activating mutations in BRAF (with a frequency of 40–60% in melanomas), NRAS, and KIT, as well as gene fusions, can signal through the MAPK and PI3K pathways, leading to uncontrolled cellular growth, proliferation, and survival (Figure 2). This evidence concerns the gene KIT and melanoma.